Ranolazine Tablet, Film Coated, Extended Release
Product Images NDC 50268-722

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ranolazine (NDC 50268-722). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avpak, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

50 (722 15)

Ranolazine Extended Release Tablets 500 mg film-coated oral tablets label by AvPAK. Package contains 50 tablets in unit dose (5 x 10) format. The label includes storage instructions, usage warnings, manufacturer details, and a barcode with NDC 50268-722-15.*

FDA Label Image

30 (723 13)

Ranolazine Extended Release Tablets 1000 mg film-coated oral tablets by AvPAK. The label indicates prescription use only with 30 tablets per package (3 x 10 unit dose). Storage instructions specify 25°C with excursions allowed between 15° to 30°C. The label includes the NDC 50268-723-13 and manufacturer details for AvKARE in Pulaski, TN.*

FDA Label Image

Ranolazine-structure (Ranolazine Structure)

Chemical structure of ranolazine, showing the molecular arrangement of its atoms and bonds as part of the drug's chemical composition.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.